Long-term efficacy and safety of idebenone in patients with LHON in the chronic phase: Results from the LEROS study

被引：0
|
作者：
Lloria, Xavier [1 ]
Tomasso, Livia [1 ]
Klopstock, Thomas [2 ]
机构：
[1] Chiesi Farmaceut SpA, Parma, Emilia Romagna, Italy
[2] Ludwig Maximilians Univ Munchen, Dept Neurol, Munich, Germany
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1581
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Long-term efficacy and safety of idebenone in patients with LHON in the subacute/dynamic phase: Results from the LEROS study
    Klopstock, Thomas
    Tomasso, Livia
    Lloria, Xavier
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [2] Long-term efficacy of idebenone in patients with LHON according to sex and disease phase: Results from the LEROS study
    Klopstock, T.
    Carelli, V.
    Yu-Wai-Man, P.
    La Morgia, C.
    Tomasso, L.
    Lloria, X.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 178 - 179
  • [3] Long-term efficacy of idebenone in patients with LHON according to age at onset and disease phase: Results from the LEROS study
    Tomasso, Livia
    Carelli, Valerio
    La Morgia, Chiara
    Yu-Wai-Man, Patrick
    Lloria, Xavier
    Klopstock, Thomas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [4] Long-term efficacy and safety of idebenone in patients with Leber's hereditary optic neuropathy (LHON) in the chronic phase: Results from the prospective, natural history-controlled LEROS study
    Yu-Wai-Man, Patrick
    Carelli, Valerio
    Tomasso, Livia
    Klopstock, Thomas
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [5] Long-term efficacy and safety of idebenone in patients with Leber's hereditary optic neuropathy (LHON) in the subacute/dynamic phase: Results from the prospective, natural historycontrolled LEROS study
    Yu-Wai-Man, Patrick
    Carelli, Valerio
    Tomasso, Livia
    Klopstock, Thomas
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [6] Long-term clinical benefit of idebenone in LHON: Results from the prospective, natural history-controlled LEROS study
    Klopstock, T.
    Tomasso, L.
    Lloria, X.
    Carelli, V.
    Man, P. Yu Wai
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 165 - 165
  • [7] Long-term efficacy of idebenone in patients with Leber hereditary optic neuropathy according to age at symptom onset and disease phase: Results from the LEROS study
    Lloria, Xavier
    Yu-Wai-Man, Patrick
    Carelli, Valerio
    Tomasso, Livia
    Klopstock, Thomas
    ACTA OPHTHALMOLOGICA, 2024, 102
  • [8] Long-term safety of idebenone in patients with Leber hereditary optic neuropathy: Results from the PAROS study
    Pemp, Berthold
    Klopstock, Thomas
    Lloria, Xavier
    Carelli, Valerio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [9] Long-term efficacy of idebenone in patients with Leber hereditary optic neuropathy in the LEROS study: Analysing change in visual acuity according to causative mutation and disease phase
    Yu-Wai-Man, Patrick
    Carelli, Valerio
    Lloria, Xavier
    Tomasso, Livia
    Klopstock, Thomas
    ACTA OPHTHALMOLOGICA, 2024, 102
  • [10] Adalimumab long-term safety/efficacy results for pediatric patients with chronic plaque psoriasis from a phase 3, randomized study
    Papp, Kim
    Marcoux, Danielle
    Landells, Ian
    Weibel, Lisa
    Ghislain, Pierre-Dominique
    Unnebrink, Kristina
    Williams, David
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB209 - AB209
12345